Traumatic Brain Injuries Assessment Market - Top Companies and Manufacturers

In the News

• In October 2024, Roche and the U.S. Biomedical Advanced Research and Development Authority (BARDA) Burn and Blast Medical Countermeasures Program, collaborated to expedite innovation around traumatic brain injuries.
• In February 2024, Philips and Synthetic MR announced Smart Quant Neuro 3D, an innovative tool aimed at improving objective decision support in diagnosing and treating brain disorders such as TBI, multiple sclerosis (MS), and dementia. This partnership signifies a significant development in neuroimaging technology, promising to improve diagnostic precision and treatment efficiency for patients with complex neurological conditions.
• In March 2023, Abbott received US Food and Drug Administration clearance for the first commercially available laboratory TBI blood test, making it widely available to hospitals in the United States. The test, which runs on Abbott's Alinity I laboratory instrument, provides clinicians with an objective way to rapidly assess individuals with mild TBIs, also known as concussions.
• In March 2022, Oculogica launched the new EyeBOX device, battery-operated, lightweight, and small enough to fit in a backpack which makes it easy to use in both sports and clinical settings. This development benefited the company by improving the usability and portability of its product, thereby broadening its market reach and growing its appeal to a wider range of healthcare providers and sports organizations.